STAAR Surgical | STAA - Operating Profit


STAAR Surgical reported $-10.93M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Bausch Health Companies USD 719M 2M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Cerus USD -1.45M 488K Dec/2024
Cooper Companies USD 212.8M 72.4M Dec/2025
Exact Sciences USD -25M 22.85M Sep/2025
Hologic USD 237M 16M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Novartis USD 4.5B 363M Sep/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Orthofix International USD 6.12M 1.91M Dec/2025
Rockwell Medical USD 515K 1.84M Jun/2024
STAAR Surgical USD -10.93M 29.42M Dec/2025
Utah Medical Products USD 3.76M 310K Sep/2024